Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. MicroRNA (miRNA), a class of noncoding single-stranded RNA molecules, is involved in regulating cancer cell proliferation, metastasis, migration, invasion, and apoptosis. We showed that the expression of miR-346 was significantly increased in HCC tissues and cell lines, compared with noncancerous controls, and was associated with poor prognosis. Overexpression of miR-346 promoted proliferation and inhibited apoptosis of SMMC-7721 cells, while knockdown of miR-346 significantly suppressed proliferation and induced apoptosis of HepG2 cells. Then we identified breast cancer metastasis suppressor 1 (BRMS1) as a direct target of miR-346 based on luciferase reporter assays. There was a negative correlation between miR-346 and BRMS1 expression at both the protein and mRNA levels. Furthermore, inhibition of BRMS1 expression reversed the tumor-suppression effects of miR-346 downregulation in HepG2 cells. These results indicate that miR-346 promotes HCC progression by regulating BRMS1 expression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844707PMC
http://dx.doi.org/10.3727/096504017X15145088802439DOI Listing

Publication Analysis

Top Keywords

brms1 expression
12
mir-346
8
mir-346 promotes
8
promotes hcc
8
hcc progression
8
breast cancer
8
cancer metastasis
8
metastasis suppressor
8
hepg2 cells
8
expression
5

Similar Publications

Article Synopsis
  • The study investigates the genetic landscape of non-small cell lung cancer (NSCLC) and its impact on resistance to osimertinib, using liquid biopsy to identify resistance mechanisms.
  • It analyzed plasma-circulating free DNA (cfDNA) and circulating tumor cells (CTCs) from 30 NSCLC patients, detecting various molecular alterations that could indicate resistance to treatment.
  • Findings revealed discrepancies in the mutation presence between cfDNA and CTCs, suggesting that combining both analyses provides a broader understanding of resistance and potential treatment options.
View Article and Find Full Text PDF

Apitherapy has started to gain tremendous recognition because of extraordinary pharmacological importance of honeybee-related ingredients and their derivatives. There has been a renewed interest in the bee venom-based therapies. Interdisciplinary researchers are studying the chemistry and translational value of venom for effective cancer treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Anoikis is a type of programmed cell death that occurs when cells detach from their surrounding matrix, and resistance to this process is a key factor in cancer progression, especially in glioblastoma (GBM).
  • The study used advanced techniques like single-cell RNA sequencing and co-culture experiments to analyze the tumor microenvironment (TME) in GBM, focusing on specific cell clusters and their gene signatures associated with anoikis.
  • Findings revealed that certain immune cells in the TME, particularly BRMS1 + microglia, play a significant role in regulating tumor cell behaviors such as invasion and resistance to therapy, indicating potential targets for therapeutic interventions.
View Article and Find Full Text PDF

ZNF623 contributes to breast carcinoma progress by recruiting CtBP1 to regulate NF-κB pathway.

Biochem Biophys Res Commun

October 2024

Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China. Electronic address:

Background: Breast cancer ranks among the most prevalent tumor types worldwide. Copy number amplification of chromosome 8q24 is frequently detected in breast cancer. ZNF623 is a relatively unexplored gene mapped to 8q24.

View Article and Find Full Text PDF

BRMS1 in Gliomas-An Expression Analysis.

Cancers (Basel)

May 2023

Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany.

The metastatic suppressor BRMS1 interacts with critical steps of the metastatic cascade in many cancer entities. As gliomas rarely metastasize, BRMS1 has mainly been neglected in glioma research. However, its interaction partners, such as NFκB, VEGF, or MMPs, are old acquaintances in neurooncology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!